ReviewBioMed research international2015

Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.

Nikolas K Haass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.